Gerresheimer AG, a global supplier to the pharma and healthcare industry, announces in a news release that it is investing 25 million euros in expanding the production capacity of its production facility in Pfreimd in southern Germany.

The company says this is a further investment driven by high customer demand for complex plastic systems for pharmaceutical and medical applications. A new production hall will be built where medical plastic systems will be manufactured in clean room environments with injection molding machines. As a result of this project around 130 new jobs will be created in Pfreimd.

"There has been a sharp increase in demand for medical delivery systems which are simple and safe for patients to use. These include injection systems, insulin pens and inhalers. We are increasing our production capacity so that we can drive future growth in this market," commented Uwe Röhrhoff, CEO of Gerresheimer.

According to the news release on December 19, the Plastic Systems division is now one of Gerresheimer's fastest-growing divisions. It produces insulin pens for diabetics, inhalers for asthma sufferers, lancing devices and disposable laboratory articles from the initial design sketches, through tool making and production to packaging and just-in-time delivery.

Inhalers, diabetic supplies such as insulin pens, lancing devices, lancets and disposable laboratory articles are some of the products manufactured in Pfreimd. The plant currently has 550 employees.

Gerresheimer AG, a global supplier to the pharma and healthcare industry, announces in a news release that it is investing 25 million euros in expanding the production capacity of its production facility in Pfreimd in southern Germany.

The company says this is a further investment driven by high customer demand for complex plastic systems for pharmaceutical and medical applications. A new production hall will be built where medical plastic systems will be manufactured in clean room environments with injection molding machines. As a result of this project around 130 new jobs will be created in Pfreimd.

"There has been a sharp increase in demand for medical delivery systems which are simple and safe for patients to use. These include injection systems, insulin pens and inhalers. We are increasing our production capacity so that we can drive future growth in this market," commented Uwe Röhrhoff, CEO of Gerresheimer.

According to the news release on December 19, the Plastic Systems division is now one of Gerresheimer's fastest-growing divisions. It produces insulin pens for diabetics, inhalers for asthma sufferers, lancing devices and disposable laboratory articles from the initial design sketches, through tool making and production to packaging and just-in-time delivery.

Inhalers, diabetic supplies such as insulin pens, lancing devices, lancets and disposable laboratory articles are some of the products manufactured in Pfreimd. The plant currently has 550 employees.